デフォルト表紙
市場調査レポート
商品コード
1688149

半導体バイオチップ市場レポート:動向、予測、競合分析 (2031年まで)

Semiconductor Biochip Market Report: Trends, Forecast and Competitive Analysis to 2031


出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

半導体バイオチップ市場レポート:動向、予測、競合分析 (2031年まで)
出版日: 2025年03月21日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の半導体バイオチップ市場の将来は、医療、ライフサイエンス、製薬、農業市場での機会で有望視されています。世界の半導体バイオチップ市場は、2025年から2031年にかけてCAGR 18.2%で成長すると予想されています。この市場の主な促進要因は、個別化医療とポイントオブケア診断の需要増加、ゲノムとプロテオミクスにおけるバイオチップの採用拡大、医療インフラと研究開発への投資増加です。

  • Lucintelによると、種類別ではアクティブチップが予測期間中に高い成長を遂げると予測しています。
  • 用途別では、医療が最も高い成長が見込まれています。
  • 地域別では、北米が予測期間中に最も高い成長が見込まれます。

半導体バイオチップ市場の戦略的成長機会

半導体バイオチップ市場には、さまざまな応用分野にわたっていくつかの戦略的成長機会が存在します。これらの機会を総称すると、さまざまな分野に統合される可能性のある高度なバイオチップ技術に対する需要の急増を意味します。

  • 医療診断:医療は診断と個別化医療において半導体バイオチップに多くの成長機会を与えています。先端バイオチップは、より高い精度とスピードで病気を特定し、効果的な治療を可能にするため、市場成長に貢献します。
  • 医薬品開発と研究:バイオチップは医薬品開発と研究にますます使用されるようになっています。ハイスループット・スクリーニング、バイオマーカー探索、ファーマコゲノミクスのためのバイオチップ開発には機会があり、製薬業界のイノベーションを促進しています。
  • 環境モニタリング:バイオチップを環境モニタリングに利用することへの関心が高まっています。これらのバイオチップは汚染物質や有害物質を検出することができ、環境保護やコンプライアンスに貴重なデータを提供します。
  • 農業用途:半導体バイオチップは、農作物のモニタリングや害虫の検出など、農業用途向けに開発されています。これらのバイオチップは、農業の生産性と持続可能性を向上させるソリューションを提供します。
  • 消費者の健康と福祉:バイオチップ技術は、消費者の健康とウェルネス、特に個人の健康モニタリングへの応用が研究されています。これにより、個人の健康をリアルタイムで監視・管理するウェアラブル・バイオチップの開発機会が生まれます。

これらの戦略的成長機会は、バイオチップの様々な応用分野を示しています。医療、医薬品開発、環境モニタリング、農業、コンシューマーヘルスなど、対象となる最終用途分野の性質が、市場が提供するものを最大限に活用し、その働きかけを拡大することを可能にするイノベーションを可能にしています。

半導体バイオチップ市場の促進要因・課題

半導体バイオチップ市場の成長と開拓に影響を与える様々な促進要因・課題があります。これらを理解することで、市場内での適切なナビゲーションを確保することができます。半導体バイオチップ市場は、主に技術、経済要因、規制問題などに関連する多くの促進要因・課題の影響を受けます。これらの要因は、業界全体の進展を形作る市場内の動向を決定する上で重要です。

半導体バイオチップ市場を牽引する要因は以下の通りである:

1.個別化医療に対する需要の高まり:個別化医療への需要の高まり:個別化医療への需要の高まりに伴い、バイオチップへの需要が高まっています。バイオチップは精度の高い診断を可能にし、治療も個別化できるため、この分野での技術革新と投資が活発化しています。

2.医療支出の増加:世界の医療支出の増加は、高度な診断ツールや調査技術への需要を高めており、その結果、医療イノベーションへの投資が増えることで、半導体バイオチップ市場の成長を後押ししています。

3.多様化:バイオチップの用途はもはや従来の診断にとどまらないです。環境モニタリングや農業にも応用されています。用途の多様化は市場拡大の原動力となり、市場に新たな成長の道をもたらします。

4.戦略的提携と協力:テクノロジー企業、研究機関、医療提供者間の提携は、バイオチップ技術を強化しています。このような提携は新製品や用途を開発し、市場開拓を促進します。

半導体バイオチップ市場の課題は以下の通り:

1.規制上のハードル:バイオチップには様々な規制上のハードルがあり、非常に複雑で高価なものとなる可能性があります。変化する規格に対応し、必要な認可をタイムリーに取得するのは困難です。

2.高い開発コスト:ハイエンドのバイオチップ技術の開発には、研究開発と製造に莫大な投資が必要です。高い開発コストは、新規参入企業の市場開拓を阻み、最終的には収益性に影響を与えます。

3.データセキュリティとプライバシーの問題:バイオチップは深刻な健康関連データを扱うため、データ・セキュリティとプライバシーが重要な問題となります。データ保護とプライバシー規制の遵守が大きな課題です。

半導体バイオチップ市場の促進要因・課題は、業界の成長が様々な複雑性を特徴としていることを示しています。技術の進歩、個別化医療、医療支出の増加が市場の成長を促進するが、その一方で、規制上の課題、高い開発コスト、データセキュリティ分析など、重大な課題につながる要因もあります。これらすべての要因が最前線にある以上、市場での成功と革新が持続可能であることを確認しないわけにはいかないと思われます。

目次

第1章 エグゼクティブサマリー

第2章 世界の半導体バイオチップ市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年~2031年)

  • マクロ経済動向 (2019~2024年) と予測 (2025~2031年)
  • 世界の半導体バイオチップ市場の動向 (2019~2024年) と予測 (2025~2031年)
  • 世界の半導体バイオチップ市場:種類別
    • アクティブチップ
    • パッシブチップ
  • 世界の半導体バイオチップ市場:用途別
    • 医療
    • ライフサイエンス
    • 製薬
    • 農業
    • その他

第4章 地域別の市場動向と予測分析 (2019年~2031年)

  • 世界の半導体バイオチップ市場:地域別
  • 北米の半導体バイオチップ市場
  • 欧州の半導体バイオチップ市場
  • アジア太平洋の半導体バイオチップ市場
  • その他地域の半導体バイオチップ市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 世界の半導体バイオチップ市場の成長機会:種類別
    • 世界の半導体バイオチップ市場の成長機会:用途別
    • 世界の半導体バイオチップ市場の成長機会:地域別
  • 世界の半導体バイオチップ市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の半導体バイオチップ市場の生産能力拡大
    • 世界の半導体バイオチップ市場における企業合併・買収 (M&A)、合弁事業
    • 認証とライセンシング

第7章 主要企業のプロファイル

  • Thermo Fisher Scientific
  • Cellix
  • GE Healthcare
  • Randox
  • Biodot
  • PerkinElmer
  • Roche
目次

The future of the global semiconductor biochip market looks promising with opportunities in the medical, life science, pharmaceutical, and agricultural markets. The global semiconductor biochip market is expected to grow with a CAGR of 18.2% from 2025 to 2031. The major drivers for this market are the increasing demand for personalized medicine and point-of-care diagnostics, the growing adoption of biochips in genomics and proteomics, and rising investments in healthcare infrastructure and research and development.

  • Lucintel forecasts that, within the type category, the active chip is expected to witness higher growth over the forecast period.
  • Within the application category, medical is expected to witness the highest growth.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Semiconductor Biochip Market

The semiconductor biochip market is evolving, with a few critical trends result of constantly evolving technology and expanding sets of applications. The aforementioned are going to reshape the industrial structure and spur creativity.

  • Integration with AI and Machine Learning: Semiconductor biochips are increasingly integrated with AI and machine learning technologies. This integration enhances data analysis, improves diagnostic accuracy, and supports the development of personalized medicine, driving innovation in the biochip sector.
  • Advancements in Microarray Technology: Recent improvements in microarray technology are increasing the capabilities of semiconductor biochips. Enhanced microarrays offer higher resolution, increased multiplexing, and improved sensitivity, enabling more detailed and accurate biomolecular analysis.
  • Growth in Point-of-Care Diagnostics: The demand for point-of-care diagnostics is rising, driving innovations in semiconductor biochips designed for rapid, on-site testing. These biochips offer quick results and ease of use, addressing the need for efficient diagnostic tools in various healthcare settings.
  • Focus on Personalized Medicine: There is a growing emphasis on personalized medicine, with biochips being developed to analyze genetic information and tailor treatments to individual patients. This trend supports the advancement of customized therapies and precision diagnostics.
  • Expansion into Emerging Markets: Semiconductor biochip manufacturers are expanding their reach into emerging markets. This growth is driven by increasing healthcare needs, rising research capabilities, and investments in biotechnology infrastructure in regions such as Asia and Latin America.

While these trends are aligned to make changes in the semiconductor biochip market, there is a greater integration of advanced technologies, and with it, an improved ability to diagnose conditions. More applications are being found. The current focus is on AI, microarray advances, point-of-care diagnostics, and personalized medicine, inspiring innovation and driving growth in the sector.

Recent Developments in the Semiconductor Biochip Market

Recent developments in the semiconductor biochip market reveal advances in technology, increased applications, and strategic investments. These key happenings will shape the future of the market.

  • Innovation in Biochip Technologies: Companies are investing in research and development to improve biochip technologies, such as the sensitivity of sensors and data processing. These innovations further enhance the performance of biochips in diagnostics, research, and other applications.
  • Manufacturing Capability Expansion: There is clear expansion of manufacturing capabilities to meet the growing demand for biochips. New facilities and enhanced production processes further ramp up output and promote the growth of the market segment.
  • Deals and Partnerships: Strategic partnerships between technology companies, research institutions, and healthcare systems further advancements in biochip technologies. Such partnerships will hasten the process of finding new uses and integrating these with already-developed healthcare systems.
  • Increased Data Integration: The integration of biochips with data analytic platforms increases their functionality for research and diagnostic purposes. Advanced data processing and integration capabilities enhance the precision and speed of analyses based on biochips.
  • Regulatory improvements have progressed to meet the unique demands of this technology and provide updated guidelines for diagnostics and research using biochips appropriately.

Advancing technology, growing capacities, and strategic partnerships are driving this market towards developments in data integration and changing regulations, thereby shaping the growth and application areas of the semiconductor biochip market.

Strategic Growth Opportunities for Semiconductor Biochip Market

Several strategic growth opportunities exist in the semiconductor biochip market across various fields of application. These opportunities collectively signify a surge in the demand for advanced biochip technology with potential integrations into different fields.

  • Healthcare Diagnosis: Healthcare presents numerous growth opportunities for semiconductor biochips in diagnosis and personalized medicine. Advanced biochips can identify diseases with higher levels of accuracy and speed to enable effective treatments, thereby contributing to market growth.
  • Drug Development and Research: Biochips are increasingly used in drug development and research. Opportunities exist in developing biochips for high-throughput screening, biomarker discovery, and pharmacogenomics, driving innovation in the pharmaceutical industry.
  • Environmental Monitoring: There is growing interest in using biochips for environmental monitoring. These biochips can detect pollutants and hazardous substances, providing valuable data for environmental protection and compliance.
  • Agricultural Applications: Semiconductor biochips are being developed for agricultural applications, including crop monitoring and pest detection. These biochips offer solutions for improving agricultural productivity and sustainability.
  • Consumer Health and Wellness: Biochip technologies are being studied for use in consumer health and wellness, especially personal health monitoring. This creates opportunities for the development of wearable biochips to monitor and manage individual health in real-time.

These strategic growth opportunities demonstrate different areas of application for biochips. The nature of targeted end-use sectors, such as healthcare, drug development, environmental monitoring, agriculture, and consumer health, allows innovation to enable the market to maximize its offerings and expand its outreach.

Semiconductor Biochip Market Driver and Challenges

There are various drivers and challenges that influence the growth and development of the semiconductor biochip market. Understanding these will help ensure proper navigation within the market. The semiconductor biochip market is influenced by a host of drivers and challenges, mainly relating to technology, economic factors, and regulatory issues, among others. These factors are important in determining the trends within the market, which shape the progress of the industry as a whole.

The factors responsible for driving the semiconductor biochip market include:

1. Growing Demand for Personalized Medicine: There is a growing demand for biochips along with the rising demand for personalized medicine. Biochips facilitate diagnostics with high levels of precision; thus, treatments can also be personalized, which is driving more innovation and investment in this area.

2. Increased Healthcare Spend: Increased healthcare spending worldwide is raising demand for advanced diagnostic tools and research technologies, which, in turn, helps the semiconductor biochip market grow by investing more in healthcare innovations.

3. Diversification: The applications of biochips are no longer confined to conventional diagnostics. It also finds applications in environmental monitoring and agriculture. The diversified applications drive market expansion and hence create newer avenues of growth for the market.

4. Strategic Partnerships and Collaborations: The collaborations between technology companies, research institutions, and healthcare providers are enhancing biochip technologies. Such partnerships develop new products and applications, thus fostering market growth.

Challenges in the semiconductor biochip market are:

1. Regulatory Hurdles: There are various regulatory hurdles regarding biochips, which can be very complex and expensive. It is difficult to comply with changing standards and to secure necessary approvals in a timely manner.

2. High Development Cost: The development of high-end biochip technologies requires huge investments in R&D and manufacturing. High development costs reduce market entry by any new player, ultimately affecting profitability.

3. Data Security and Privacy Issue: Biochips deal with serious health-related data; hence, data security and privacy are the prime issues. Addressing the concerns of data protection and compliance with privacy regulations is a major challenge.

The drivers and challenges to the semiconductor biochip market indicate that industry growth is characterized by various complexities. Technological advancement, personalized medicine, and rising healthcare expenditure drive the growth in the market, but on the other hand, some factors contribute towards significant challenges, including regulatory challenges, high development costs, and data security analysis. With all these factors at the forefront, it will be impossible not to make sure that success and innovation are sustainable in the market.

List of Semiconductor Biochip Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies semiconductor biochip companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the semiconductor biochip companies profiled in this report include-

  • Thermo Fisher Scientific
  • Cellix
  • GE Healthcare
  • Randox
  • Biodot
  • PerkinElmer
  • Roche

Semiconductor Biochip by Segment

The study includes a forecast for the global semiconductor biochip market by type, application, and region.

Semiconductor Biochip Market by Type [Analysis by Value from 2019 to 2031]:

  • Active Chips
  • Passive Chips

Semiconductor Biochip Market by Application [Analysis by Value from 2019 to 2031]:

  • Medical
  • Life Science
  • Pharmaceutical
  • Agricultural
  • Others

Semiconductor Biochip Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Semiconductor Biochip Market

The semiconductor biochip market is one of the fastest-evolving markets in modern times due to rapid advancements in technology, an increase in applications, and continuous changes in regulations. Recent developments across different major regions, such as the United States, China, Germany, India, and Japan, illuminate the global growth and transformation in the sector.

  • United States: Due to high investment in research and development and healthcare-based application development, growth has been recorded in the US semiconductor biochip market. The emergence of precision medicine and personalized diagnostics increases demand for biochips with higher functionality and greater accuracy.
  • China: China is investing significantly in the research development and manufacturing of semiconductor biochips to enhance its biotechnology industry. Emphasis is being placed on increasing manufacturing capacities and integrating biochips into various diagnostic and research applications.
  • Germany: Germany represents a semiconductor biochip market where innovations and integrations are essential prerequisites in the existing German health system. Countries like Germany have tech firms and research institutions cooperating in the advancement of technology to make biochips applicable for medical diagnostics and drug development.
  • India: India presents a fast-evolving semiconductor biochip market, with a wide array of healthcare infrastructure and research facilities. Recent developments include low-cost biochip solutions to meet local healthcare needs and the requirements of its emerging biotech sector.
  • Japan: Japan is making state-of-the-art contributions to semiconductor biochip technologies for applications related to genomics and personalized medicine. Key recent developments include advances in microarray technologies and their integration with artificial intelligence, enhancing data analytics and diagnostics.

Features of the Global Semiconductor Biochip Market

Market Size Estimates: Semiconductor biochip market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Semiconductor biochip market size by type, application, and region in terms of value ($B).

Regional Analysis: Semiconductor biochip market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the semiconductor biochip market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the semiconductor biochip market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the semiconductor biochip market by type (active chips and passive chips), application (medical, life science, pharmaceutical, agricultural, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Semiconductor Biochip Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Semiconductor Biochip Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Semiconductor Biochip Market by Type
    • 3.3.1: Active Chips
    • 3.3.2: Passive Chips
  • 3.4: Global Semiconductor Biochip Market by Application
    • 3.4.1: Medical
    • 3.4.2: Life Science
    • 3.4.3: Pharmaceutical
    • 3.4.4: Agricultural
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Semiconductor Biochip Market by Region
  • 4.2: North American Semiconductor Biochip Market
    • 4.2.1: North American Market by Type: Active Chips and Passive Chips
    • 4.2.2: North American Market by Application: Medical, Life Science, Pharmaceutical, Agricultural, and Others
  • 4.3: European Semiconductor Biochip Market
    • 4.3.1: European Market by Type: Active Chips and Passive Chips
    • 4.3.2: European Market by Application: Medical, Life Science, Pharmaceutical, Agricultural, and Others
  • 4.4: APAC Semiconductor Biochip Market
    • 4.4.1: APAC Market by Type: Active Chips and Passive Chips
    • 4.4.2: APAC Market by Application: Medical, Life Science, Pharmaceutical, Agricultural, and Others
  • 4.5: ROW Semiconductor Biochip Market
    • 4.5.1: ROW Market by Type: Active Chips and Passive Chips
    • 4.5.2: ROW Market by Application: Medical, Life Science, Pharmaceutical, Agricultural, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Semiconductor Biochip Market by Type
    • 6.1.2: Growth Opportunities for the Global Semiconductor Biochip Market by Application
    • 6.1.3: Growth Opportunities for the Global Semiconductor Biochip Market by Region
  • 6.2: Emerging Trends in the Global Semiconductor Biochip Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Semiconductor Biochip Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Semiconductor Biochip Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Cellix
  • 7.3: GE Healthcare
  • 7.4: Randox
  • 7.5: Biodot
  • 7.6: PerkinElmer
  • 7.7: Roche